Free Trial
OTCMKTS:BAYRY

Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis

Bayer Aktiengesellschaft logo
$10.20 +0.01 (+0.10%)
As of 03:17 PM Eastern

About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)

Advanced

Key Stats

Today's Range
$10.10
$10.23
50-Day Range
$9.88
$12.12
52-Week Range
$7.19
$14.85
Volume
688,315 shs
Average Volume
1.38 million shs
Market Capitalization
$40.09 billion
P/E Ratio
N/A
Dividend Yield
0.20%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Bayer Aktiengesellschaft Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

BAYRY MarketRank™: 

Bayer Aktiengesellschaft scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bayer Aktiengesellschaft has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 5 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Bayer Aktiengesellschaft has only been the subject of 4 research reports in the past 90 days.

  • Read more about Bayer Aktiengesellschaft's stock forecast and price target.
  • Earnings Growth

    Earnings for Bayer Aktiengesellschaft are expected to grow by 5.60% in the coming year, from $1.25 to $1.32 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bayer Aktiengesellschaft is -15.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bayer Aktiengesellschaft is -15.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Bayer Aktiengesellschaft has a PEG Ratio of 3.26. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Bayer Aktiengesellschaft has a P/B Ratio of 1.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Bayer Aktiengesellschaft's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Bayer Aktiengesellschaft has been sold short.
  • Short Interest Ratio / Days to Cover

    Bayer Aktiengesellschaft has a short interest ratio ("days to cover") of 0.03, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bayer Aktiengesellschaft has recently decreased by 29.46%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bayer Aktiengesellschaft has a dividend yield of 0.23%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Bayer Aktiengesellschaft does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Bayer Aktiengesellschaft will have a dividend payout ratio of 1.52% next year. This indicates that Bayer Aktiengesellschaft will be able to sustain or increase its dividend.

  • Read more about Bayer Aktiengesellschaft's dividend.
  • News Sentiment

    Bayer Aktiengesellschaft has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Bayer Aktiengesellschaft this week, compared to 7 articles on an average week.
Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BAYRY Stock News Headlines

I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
See More Headlines

BAYRY Stock Analysis - Frequently Asked Questions

Bayer Aktiengesellschaft's stock was trading at $10.82 at the beginning of 2026. Since then, BAYRY shares have decreased by 6.4% and is now trading at $10.13.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) released its quarterly earnings results on Tuesday, May, 12th. The company reported $0.79 EPS for the quarter, beating the consensus estimate of $0.64 by $0.15. The company earned $15.73 billion during the quarter, compared to the consensus estimate of $15.77 billion. Bayer Aktiengesellschaft had a negative net margin of 4.75% and a positive trailing twelve-month return on equity of 17.74%.

Bayer Aktiengesellschaft subsidiaries include Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and more.

Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/12/2026
Today
6/10/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
N/A
Current Symbol
OTCMKTS:BAYRY
CIK
1144145
Employees
88,078
Year Founded
1863

Profitability

EPS (Trailing Twelve Months)
($0.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.16
P/E Growth
3.26
Net Income
-$4.10 billion
Net Margins
-4.75%
Pretax Margin
-6.87%
Return on Equity
17.74%
Return on Assets
4.88%

Debt

Debt-to-Equity Ratio
1.22
Current Ratio
1.01
Quick Ratio
0.63

Sales & Book Value

Annual Sales
$51.55 billion
Price / Sales
0.78
Cash Flow
$2.19 per share
Price / Cash Flow
4.65
Book Value
$7.50 per share
Price / Book
1.36

Miscellaneous

Outstanding Shares
3,930,000,000
Free Float
N/A
Market Cap
$40.09 billion
Optionable
Not Optionable
Beta
0.59

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:BAYRY) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners